Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

Online
ISSN
1437-4331
See all formats and pricing
Volume 44, Issue 2 (Feb 2006)

Issues

Laboratory network of excellence: enhancing patient safety and service effectiveness

Mario Plebani
  • Department of Laboratory Medicine, University-Hospital of Padova, Padova, Italy
/ Ferruccio Ceriotti
  • Diagnostica e Ricerca, San Raffaele SpA, Milan, Italy
/ Gianni Messeri
  • Central Laboratory, University-Hospital of Florence, Florence, Italy
/ Cosimo Ottomano
  • Laboratory Medicine, Ospedali Riuniti, Bergamo, Italy
/ Nicola Pansini
  • Patologia Clinica I, University-Hospital of Bari, Bari, Italy
/ Pierangelo Bonini
  • Università Vita e Salute, Diagnostica e Ricerca, San Raffaele SpA, Milan, Italy
Published Online: 2006-02-13 | DOI: https://doi.org/10.1515/CCLM.2006.028

Abstract

Clinical laboratories have undergone major changes due to technological progress and economic pressure. While costs of laboratory testing continue to be the dominant issue within the healthcare service worldwide, quality, effectiveness and impact on outcomes are also emerging as critical value-added features. Five Italian laboratories are therefore promoting a network of excellence by investigating markers of effectiveness of laboratory services and sharing their experience of using them in clinical practice. In the present study we report preliminary data on indicators of quality in all phases of the so-called total testing process, the key to evaluating all phases of the total testing process, including the appropriateness of test requests and data interpretation. Initial findings in evaluating pre-analytical causes of specimen rejection in three different laboratories and the effects of introducing three laboratory clinical guidelines are reported. These data should stimulate debate in the scientific community and encourage more clinical laboratories to use the same indicators to improve clinical effectiveness and clinical outcomes within the healthcare service.

Keywords: clinical outcomes; errors and risk of error; laboratory network; patient safety quality indicators; total testing process

References

  • 1.

    Plebani M. The changing face of clinical laboratories. Clin Chem Lab Med 1999; 37:711–7. [Crossref]

  • 2.

    Gray TA. Clinical governance. Ann Clin Biochem 2000; 37:9–15. [Crossref]

  • 3.

    Plebani M. Role of inspectors in external review mechanisms: criteria for selection, training and appraisal. Clin Chim Acta 2001; 309:147–54.

  • 4.

    Price CP. Evidence-based laboratory medicine: supporting decision-making. Clin Chem 2000; 46:1041–50.

  • 5.

    Waise A, Plebani M. Which surrogate marker can be used to assess the effectiveness of the laboratory and its contribution to clinical outcome? Ann Clin Biochem 2001; 38:589–95. [Crossref]

  • 6.

    Konh LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Washington, DC: Academic Press, 2000.

  • 7.

    Plebani M, Carraro P. Mistakes in a stat laboratory: types and frequency. Clin Chem 1997; 43:1348–51.

  • 8.

    Bonini PA, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002; 48:691–8.

  • 9.

    Stroobants AK, Goldschmidt HM, Plebani M. Error budget calculations in laboratory medicine: linking the concepts of biological variation and allowable medical errors. Clin Chim Acta 2003; 333:169–76.

  • 10.

    Holman JW, Mifflin TE, Felder RA, Demers LM. Evaluation of an automated preanalytical robotic workstation at two academic health centers. Clin Chem 2002; 48:540–8.

  • 11.

    Ricos C, Garcia-Victoria M, de la Fuente B. Quality indicators and specifications for the extra-analytical phases in clinical laboratory management. Clin Chem Lab Med 2004; 42:578–82. [Crossref]

  • 12.

    Draft Federal Information Processing Standards Publication 183. Integration definition for function modelling (idef). www.Idef.com/Downloads/pdf/idef0.pdf, 1993.

  • 13.

    Redmill F, Chudleigh M, Catmur J. System safety: HAZOP and Software HAZOP. Chichester: John Wiley & Sons, 1999.

  • 14.

    Schraagen JM, Chipman SF, Shalin VL. Cognitive task analysis. Mahwah, NJ: Lawrence Erlbaum Associates, 2000.

  • 15.

    Bonini P, Ceriotti F, Gaia M. Total laboratory error: inevitable or avoidable. Clin Chim Acta 2005; 355:s46–7.

  • 16.

    Proposed ISO/DTR 22367. Medical laboratories – reduction of error through risk management and continual improvement – complementary element. Version 2.1c2. ISO, 2005.

  • 17.

    Jones BA, Calam RR, Howanitz PJ. Chemistry specimen acceptability. Arch Pathol Lab Med 1997; 121:19–26.

  • 18.

    Field MJ, Lohr KN, editors. Guidelines for clinical practice. From development to use. Washington, DC: National Academy Press, 1992.

  • 19.

    Oosterhuis WP, Bruns DE, Watine J, Sandberg S, Horvath AR. Evidence-based guidelines in laboratory medicine: principles and methods. Clin Chem 2004; 50:806–18. [Crossref]

  • 20.

    Demers EM, Spencer CA. Laboratory support for the diagnosis and monitoring of thyroid disease. The National Academy of Clinical Biochemistry, 2003 (http://www.nacb.org/lmpg/thyroid_lmpg_pub.stm).

  • 21.

    Hamm CW, Bertrand M, Braunwald E. Acute coronary syndrome without ST elevation: implementation of new guidelines. Lancet 2001; 358:1533–8.

  • 22.

    Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002; 117:316–24.

  • 23.

    ISO 15189. Medical laboratories – particular requirements for quality and competence. ISO, 2003. [Web of Science]

  • 24.

    Laposata M. Patient-specific narrative interpretation of complex clinical laboratory evaluations: who is competent to provide them? Clin Chem 2004; 50:471–2. [Crossref]

  • 25.

    Kilpatrick ES. Can the addition of interpretative comments to laboratory reports influence outcome? An example involving patients taking thyroxine. Ann Clin Biochem 2004; 41:227–9. [Crossref]

  • 26.

    Fraser CG, Hyltoft Petersen P. Analytical performance characteristics should be judged against objective quality specifications. Clin Chem 1999; 45:321–3.

  • 27.

    Plebani M. What information on quality specifications should be communicated to clinicians, and how? Clin Chim Acta 2004; 346:25–35.

  • 28.

    Kyle RA, Rajkumar SV. Monoclonal gammopathies of undetermined significance. Rev Clin Exp Hematol 2002; 63:225–52. [Crossref]

  • 29.

    Carraro P, Servidio G, Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem 2000; 46:306–7.

  • 30.

    Wilson ML. Appropriate use of clinical microbiology tests. Clin Lab Med 2002; 22:491–503. [Crossref]

  • 31.

    Toybert ME, Chevret S, Cassinat B, Schlageter MH, Beressi JP, Rain JD. From guidelines to hospital practice: reducing inappropriate ordering of thyroid hormone and antibody tests. Eur J Endocrinol 200; 142:605–10.

  • 32.

    Keren DF. Antinuclear antibody testing. Clin Lab Med 2002; 22:447–74. [Crossref]

  • 33.

    Howanitz PG, Tetrault GA, Steindel SJ. Clinical laboratory quality control: a costly process now out of control. Clin Chim Acta 1997; 260:163–74.

  • 34.

    Henny J, Petersen HP. Reference values: from philosophy to a tool for laboratory medicine. Clin Chem Lab Med 2004; 42:686–91. [Crossref]

  • 35.

    Grasbeck R. The evolution of the reference value concept. Clin Chem Lab Med 2004; 42:692–7. [Crossref]

  • 36.

    Plebani M. Charting the course of medical laboratories in a changing environment. Clin Chim Acta 2002; 319:87–100.

  • 37.

    Fraser CG. Inherent biological variation and reference values. Clin Chem Lab Med 2004; 42:758–64. [Crossref]

  • 38.

    Forsman RW. Why is the laboratory an afterthought for managed care organizations? Clin Chem 1996; 42:813–6.

  • 39.

    Provonost PJ, Nolan T, Zeger S, Miller M, Rubin H. How can clinicians measure safety and quality in acute care? Lancet 2004; 363:1061–7.

  • 40.

    Plebani M. Towards quality specifications in extra-analytical phases of laboratory activity. Clin Chem Lab Med 2004; 42:578–82. [Crossref]

About the article

Corresponding author: Prof. Dr. Mario Plebani, Department of Laboratory Medicine, University Hospital of Padova, Via Nicolo Giustiniani 2, 35131 Padova, Italy


Received: 2005-09-08

Accepted: 2005-11-16

Published Online: 2006-02-13

Published in Print: 2006-02-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2006.028. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Jose L. Andrade-Pineda, Pedro L. Gonzalez-R, and Jose M. Framinan
Interfaces, 2013, Volume 43, Number 4, Page 360
[2]
M. Plebani, L. Sciacovelli, A. Aita, A. Padoan, and M.L. Chiozza
Clinica Chimica Acta, 2014, Volume 432, Page 44
[3]
Ángeles Giménez Marín, Pedro Molina Mendoza, José Joaquin Ruiz Arredondo, Federico Acosta González, Marisa López Pérez, Manolo Jiménez Cueva, Teresa Cueto Santamaría, Rosa Olmedo Sánchez, Mercedes López Somosierras, Francisco Rivas Ruiz, and María del Mar Pérez Hidalgo
Revista del Laboratorio Clínico, 2010, Volume 3, Number 4, Page 161
[4]
Stephen D. Krau
Critical Care Nursing Clinics of North America, 2010, Volume 22, Number 1, Page 1
[5]
Maria Salinas La Casta, Emilio Flores Pardo, and Joaquín Uris Selles
Gaceta Sanitaria, 2009, Volume 23, Number 3, Page 250
[6]
Alexandre C. Guimarães, Marilei Wolfart, Maria L.L. Brisolara, and Caroline Dani
Clinical Biochemistry, 2012, Volume 45, Number 1-2, Page 123
[7]
Laura Sciacovelli, Oswald Sonntag, Andrea Padoan, Carlo Federico Zambon, Paolo Carraro, and Mario Plebani
Clinical Chemistry and Laboratory Medicine, 2012, Volume 50, Number 3
[8]
Giuseppe Lippi, Roberto Fostini, and Gian Cesare Guidi
Clinics in Laboratory Medicine, 2008, Volume 28, Number 2, Page 285
[9]
Mario Plebani
Clinica Chimica Acta, 2009, Volume 404, Number 1, Page 59
[10]
Giuseppe Lippi and Gian Cesare Guidi
The American Journal of Emergency Medicine, 2008, Volume 26, Number 3, Page 373
[11]
Johan Söderberg, Kjell Grankvist, Christine Brulin, and Olof Wallin
Scandinavian Journal of Clinical & Laboratory Investigation, 2009, Volume 69, Number 7, Page 731
[12]
Giuseppe Lippi, Norbert Blanckaert, Pierangelo Bonini, Sol Green, Steve Kitchen, Vladimir Palicka, Anne J. Vassault, Camilla Mattiuzzi, and Mario Plebani
Clinical Chemistry and Laboratory Medicine, 2009, Volume 47, Number 2
[13]
Mario Plebani and Elisa Piva
Journal of Medical Biochemistry, 2010, Volume 29, Number 4
[14]
César Alex de Oliveira Galoro, Maria Elizabete Mendes, and Marcelo Nascimento Burattini
Benchmarking: An International Journal, 2009, Volume 16, Number 6, Page 817
[15]
Ingolf Schimke
Analytical and Bioanalytical Chemistry, 2009, Volume 393, Number 5, Page 1499
[16]
Gustáv Kováč and Anna Porubenová
Accreditation and Quality Assurance, 2008, Volume 13, Number 3, Page 165
[17]
Giuseppe Lippi, Gian Luca Salvagno, Martina Montagnana, Franco Manzato, and Gian Cesare Guidi
Blood Coagulation & Fibrinolysis, 2007, Volume 18, Number 5, Page 525

Comments (0)

Please log in or register to comment.
Log in